Skip to main content

OZOLEA-MAST

This treatment applies to the following species:
Company: Ozolea

Animal device - Veterinary device for intra-mammary use in dairy cows

Suitable for lactating and dry-off applications.

No chemical residues in milk and meat.

Description

OZOLEA-MAST contains a food-grade vegetable oil, bioengineered to provide a physical barrier to the inner wall of the teat canal, without any pharmacological or metabolic effect. It supports tissue functionality when not severely compromised.

Not cytotoxic (UNI EN ISO 10993-5 Standard).

Suitable for lactating animals (dairy, sheep, goats).

For Animal Use Only

Packaging

Each box contains 5 packs of 8 Single-use applicators (5 ml-0,169 fl.oz. each)

Ingredients

Ingredients: Ozonized Zea Mays Germ Oil

[California only: Active Ingredients: Ozonized Zea Mays Germ Oil (100%)]

OZOLEA-MAST is designed to exert a merely physical effect.

OZOLEA-MAST complies with the definition of animal device provided by FDA here https: / / www.fda.gov / animal - veterinary / animal - health - literacy / how - fda - regulates - animal - devices.

Storage

Best storage: 39-50°F / 4-10°C

Storage: max 20°C/68°F

Instructions

LACTATING USE - Do not wait for a full-blown mastitis: act promptly at the very first signs of tissue unbalance (i.e. altered milk or electrical conductivity warning). Detect the sensitive quarter and gently insert the single-use applicator into the teat canal at the end of milking. Apply and rub gently. Observe best hygiene practices. Repeat twice a day for four days (or after each milking for a total of 8 applications).

For better results and support tissue functionality, repeat the application and observe Ozolea protocols.

DRY-OFF USE - One single-use applicator to each quarter at the second to last milking and one single use applicator to each quarter at the last milking. OZOLEA-MAST is meant to be used for cows suitable for selective dry protocols.

Protocols

OZOLEA-MAST is your new ally in lactation and at dry-off.

You can use OZOLEA-MAST on several occasions according to SSafeMILK® protocols:

M1 - MILK FLAKES

M2 - POST-PARTUM- AFTER CALVING

M3 - HIGH SOMATIC CELL COUNT

M4 - FREQUENT RELAPSES

M5 - WAITING FOR LAB TESTS - Ask your Veterinarian

M6 - SYNERGY WITH AN ANTIBIOTIC TREATMENT - Ask your Veterinarian

M7 - ELECTRICAL CONDUCTIVITY WARNING

M8 - SELECTIVE DRY-OFF

M9 - SELECTIVE DRY-OFF QUARTER BY QUARTER

Ask your Veterinarian or contact us to receive a copy of SSafeMILK® protocols.

Join our Facebook group OZOLEA USA for updates, suggestions and new field data. Due to our company policy and our commitment to address scientifically the global issue of antimicrobial resistance, protocols M5 and M6 require the participation of your Veterinarian to be implemented.

Find here a brochure on OZOLEA-MAST: https: / / www.ozolea.it / wp - content / uploads / 2022 / 12 / OZOLEA - OZOLEA - MAST - Ref.CB - MA - US202002.PA5_.pdf

OZOLEA-MAST: MILK WITH NO DISCARDS!

Why withdraw your milk if you can sell it?

SELL YOUR MILK, DON’T WASTE IT!

By reducing the use of unnecessary antibiotics, you will help improve the productivity of your cows, ship more milk and contribute to the global fight to lower antimicrobial resistance.

OZOLEA-MAST is an animal device for intra-mammary use in dairy cows that helps dairy farmers reduce the use of antibiotics which are not strictly necessary, both for lactating cows and at dry-off.

OZOLEA

For You, for animals, for the environment.

OZOLEA Rete Agricola, Castegnato BS ITALY

www.ozolea.it

americas@ozolea.it

US: (800) 918-0902

Ref. D-MA-2024.USA.CVP.01

03.2024

CPN: 2150000.0

OZOLEA RETA AGRICOLA
VIA CAVEZZO, 22 25045 CASTEGNATO BS, ITALY
Telephone:   +39 3292736358
    +39 0300947936
Website:   www.ozolea.it
Email:   info@ozolea.it
THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.

Animalytix

Copyright © 2024 Animalytix LLC. Updated: 2024-08-26